Trends, players and financial data 2014-2021
DUBLIN, September 28, 2021 / PRNewswire / – Gain full access to over 1,450 bioinformatics transaction records from this report, “Conditions and agreements of global partnership in bioinformatics from 2014 to 2021” which was added to ResearchAndMarkets.com offer.
The Global Bioinformatics Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to bioinformatics partnership agreements and agreements entered into by the world’s leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter into bioinformatics partnership agreements. The majority of transactions are at the discovery stage where the licensee obtains a right or option right to license the bioinformatics technology from the licensor. These agreements tend to be multi-component, starting with collaborative R&D and the commercialization of results.
Bioinformatics is the application of computer science and information technology to the field of biology and medicine. Bioinformatics deals with algorithms, databases, information systems, web technologies, artificial intelligence, information and computational theory, software engineering, data mining, image processing, modeling, simulation, signal processing, discrete mathematics, control systems and statistics, to generate new knowledge in biology and medicine.
Bioinformatics agreements have grown in popularity for partnerships over the past decade, as computing power has been embraced to accelerate the processes of discovery, evaluation, and clinical evaluation.
Understanding the flexibility of the terms of the agreements negotiated by a potential partner provides critical insight into the negotiation process in terms of what you can expect to achieve when negotiating the terms. While many small businesses will be looking for details on payment clauses, the devil is in the detail in terms of triggering payments – contract documents provide that insight where press releases and databases do not.
This report contains a complete list of all bioinformatics partnership agreements announced since January 2014, including financial terms where available, including over 1,450 links to online deal files of actual bioinformatics partnership agreements as disclosed by the parties to the agreement. Additionally, when available, records include contractual documents as submitted to the Securities Exchange Commission by the companies and their partners.
The Global Bioinformatics Partnership Terms and Agreements provide the reader with the following key benefits:
- In-depth understanding of bioinformatics transaction trends since 2014
- Access to title, advance, milestone and royalty data
- Full access to more than 1,450 bioinformatics agreements entered into by the world’s biopharmaceutical companies
- Detailed access to current bioinformatics contracts concluded by large pharmaceutical companies
- Overview of terms included in a bioinformatics agreement, as well as examples of real world clauses
- Understand the key terms of agreements that companies have agreed to in previous agreements
- Undertake due diligence to assess the adequacy of your proposed terms of agreement for partner companies
Main topics covered:
Chapter 1 Introduction
Chapter 2 – Trends in Bioinformatics Negotiations
2.2. Bioinformatics partnership over the years
2.3. The most active bioinformatics traders
2.4. Bioinformatics partnerships by type of transaction
2.5. Bioinformatics partnership by therapeutic area
2.6. Conditions of the agreement for the bioinformatics partnership
2.6.1 Key values ââof the bioinformatics partnership
2.6.2 Upfront payments for bioinformatics transactions
2.6.3 Milestone Payments for Bioinformatics Agreements
2.6.4 Bioinformatics royalty rate
Chapter 3 – Main contracts in bioinformatics
3.2. Best Bioinformatics Deals by Value
Chapter 4 – The Most Active Bioinformatics Traders
4.2. The most active bioinformatics traders
4.3. Profiles of the most active bioinformatics partner companies
Chapter 5 – Bioinformatics Contract Negotiation Directory
5.2. Directory of bioinformatics contracts
Chapter 6 – Bioinformatics Transactions by Type of Technology
Chapter 7 – Partner Resource Center
7.1. Online partnership
7.2. Partnership events
7.3. Further reading on negotiation
Annex 1 – Bioinformatics transactions by AZ company
Annex 2 – Bioinformatics offers by stage of development
Annex 3 – Transactions in bioinformatics by type of transaction
Annex 4 – Bioinformatics offers by therapeutic area
Annex 5 – Definitions of types of transactions
For more information on this report, visit https://www.researchandmarkets.com/r/fikq41
Research and markets
Laura Wood, senior
For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and Markets